Mirati Therapeutics is a San Diego-based biotechnology company that is dedicated to developing targeted therapies to improve the lives of patients. Their research and development programs focus on targeting specific mutations, such as KRASG12C and KRASG12D, in order to tackle cancer head-on. With a pipeline of novel therapeutics, Mirati is committed to converting possibility into reality and making a significant impact in the field of oncology.
Generated from the website